We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00163631
First Posted: September 14, 2005
Last Update Posted: October 4, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Bayside Health
  Purpose
Investigate vasoactive medicators in portal hypertension on stored sera

Condition
Portal Hypertension

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Official Title: Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

Resource links provided by NLM:


Further study details as provided by Bayside Health:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • portal hypertension

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00163631


Locations
Australia, Victoria
Alfred Hospital
Melbourne, Victoria, Australia, 3181
Sponsors and Collaborators
Bayside Health
Investigators
Principal Investigator: William W Kemp, MBBS FRACP The Alfred
  More Information

ClinicalTrials.gov Identifier: NCT00163631     History of Changes
Other Study ID Numbers: 4104
First Submitted: September 11, 2005
First Posted: September 14, 2005
Last Update Posted: October 4, 2006
Last Verified: September 2005

Additional relevant MeSH terms:
Hypertension, Portal
Liver Cirrhosis
Liver Diseases
Digestive System Diseases